TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

We have developed C-STEMTM :  a proprietary technology for the mass-production of cell therapies.

Our offer

Cell therapy pipeline

A series of proprietary cell therapy programs for co-development or licensing

C-Stem™ platform

A cGMP-compatible mass-production platform for cell therapies

Latest news

  • TreeFrog Therapeutics receives additional €3M non-dilutive funding to mass-produce clinical-grade cell therapies by 2021   Company awarded close to €3M ($3.3M) in public grants only five months after Series A round of €7M ($7.8M)   Bordeaux, France, September 5, 2019 – TreeFrog Therapeutics, an expert......

  • TreeFrog Therapeutics has developed C-Stem™ : a proprietary technology platform for the mass-production of iPSc-based cell therapies. C-Stem™ secures cell quality (100% genomic integrity), volumes (x100 cell amplification per week) and dramatically reduces cell therapy costs (by 10 today, by 100 tomorrow). Learn about C-Stem...

  • TreeFrog will be in Japan from the 10th to 21th of September 2019 to meet key academic and industry players ! This cell therapy roadtrip, organized with the help of Business France, will be marked by our participation to Cell Therapy Word Asia 2019 on Sept 18-19......

I am test text for Image with text shortcode.

TreeFrog Therapeutics I Stem Cell Company I Cell Therapy for all

TreeFrog Therapeutics is a French stem cell company aiming at supporting the advent and industrial development of stem cell therapies.